Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Analgesic 1,4-substituted cyclohexyl compounds in development at AstraZeneca

Jan. 28, 2000

West soon to initiate phase I testing of nasal morphine in U.S.

Jan. 27, 2000

Delta receptor ligands with potential as analgesics under study at AstraZeneca

Jan. 27, 2000

4-Arylpiperidines as 5-HT reuptake inhibitors

Jan. 26, 2000

Lilly designs new series for activating the 5-ht1f receptor

Jan. 26, 2000

New therapeutic approach to PD: adenosine A2A receptor blockade with KW-6002

Jan. 25, 2000

UC Irvine investigators uncover clue to the cause of ALS

Jan. 25, 2000

Search for effective and well-tolerated anxiolytics continues at MS&D

Jan. 25, 2000

Schering-Plough investigates new treatments for Alzheimer's disease

Jan. 25, 2000

Novel anticonvulsants remain major area of research at SmithKline Beecham

Jan. 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...